Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat - PubMed (original) (raw)
Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat
J D Roberts Jr et al. Circ Res. 1995 Feb.
Abstract
Breathing low oxygen levels for several weeks produces progressive pulmonary artery hypertension and smooth muscle hypertrophy and hyperplasia in many species. Because nitric oxide (NO) is an important regulator of pulmonary vascular tone, we examined whether the continuous inhalation of low levels of NO gas would attenuate pulmonary arterial structural changes in hypoxic rat pups. Nine-day-old rat pups and their mothers continuously breathed at FIO2 0.21 or 0.10 with or without adding 20 ppm (by volume) NO for 2 weeks. Lung tissue was obtained for vascular morphometric analysis, and the hearts were dissected to measure right ventricular weight and levels of mRNA encoding rat atrial natriuretic factor (rANF). In addition, femur and skull length were radiographically determined. Breathing at FIO2 0.10 for 14 days increased pulmonary arterial wall thickness and the proportion of muscular arteries in the lung periphery. Right ventricular weight and right ventricular rANF gene expression increased, whereas body weight and skeletal growth were reduced (all P < .05). Continuous inhalation of 20 ppm NO at FIO2 0.10 for 2 weeks decreased hypoxic pulmonary vascular structural changes and somatic growth retardation and prevented the increase of right ventricular weight and right ventricular rANF mRNA levels. These observations suggest that chronically breathing NO attenuates pulmonary vascular smooth muscle hypertrophy and/or hyperplasia and extension into distal arterial walls, right ventricular hypertrophy, and growth retardation of newborns breathing at a low oxygen level.
Similar articles
- BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P, Balasubramaniam V, Kunig AM, Seedorf GJ, Markham NE, Abman SH. Deruelle P, et al. Biol Neonate. 2006;90(2):135-44. doi: 10.1159/000092518. Epub 2006 Mar 19. Biol Neonate. 2006. PMID: 16582538 - Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
Horstman DJ, Frank DU, Rich GF. Horstman DJ, et al. Anesth Analg. 1998 Jan;86(1):74-81. doi: 10.1097/00000539-199801000-00015. Anesth Analg. 1998. PMID: 9428855 - Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats.
Tourneux P, Markham N, Seedorf G, Balasubramaniam V, Abman SH. Tourneux P, et al. Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1103-11. doi: 10.1152/ajplung.00293.2009. Epub 2009 Oct 16. Am J Physiol Lung Cell Mol Physiol. 2009. PMID: 19837849 - A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
Jiang BH, Maruyama J, Yokochi A, Mitani Y, Maruyama K. Jiang BH, et al. Lung. 2007 Sep-Oct;185(5):303-308. doi: 10.1007/s00408-007-9024-z. Epub 2007 Aug 25. Lung. 2007. PMID: 17721804 - Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups.
Roberts JD Jr, Chiche JD, Weimann J, Steudel W, Zapol WM, Bloch KD. Roberts JD Jr, et al. Circ Res. 2000 Jul 21;87(2):140-5. doi: 10.1161/01.res.87.2.140. Circ Res. 2000. PMID: 10903998
Cited by
- Soluble guanylate cyclase modulates alveolarization in the newborn lung.
Bachiller PR, Cornog KH, Kato R, Buys ES, Roberts JD Jr. Bachiller PR, et al. Am J Physiol Lung Cell Mol Physiol. 2013 Oct 15;305(8):L569-81. doi: 10.1152/ajplung.00401.2012. Epub 2013 Aug 9. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 23934926 Free PMC article. - β3 adrenergic receptor antagonist SR59230A exerts beneficial effects on right ventricular performance in monocrotaline-induced pulmonary arterial hypertension.
Sun J, Cheng J, Ding X, Chi J, Yang J, Li W. Sun J, et al. Exp Ther Med. 2020 Jan;19(1):489-498. doi: 10.3892/etm.2019.8236. Epub 2019 Nov 22. Exp Ther Med. 2020. PMID: 31853320 Free PMC article. - Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
Bachiller PR, Nakanishi H, Roberts JD Jr. Bachiller PR, et al. Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L324-34. doi: 10.1152/ajplung.00181.2009. Epub 2009 Dec 18. Am J Physiol Lung Cell Mol Physiol. 2010. PMID: 20023176 Free PMC article. - Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase.
Minamoto K, Harada H, Lama VN, Fedarau MA, Pinsky DJ. Minamoto K, et al. J Exp Med. 2005 Jul 18;202(2):283-94. doi: 10.1084/jem.20050377. J Exp Med. 2005. PMID: 16027238 Free PMC article. - Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling.
Du L, Roberts JD Jr. Du L, et al. Am J Physiol Lung Cell Mol Physiol. 2019 Jan 1;316(1):L20-L34. doi: 10.1152/ajplung.00319.2018. Epub 2018 Sep 27. Am J Physiol Lung Cell Mol Physiol. 2019. PMID: 30260287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical